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Background
We had previously shown that rhesus monkeys receiving
Ad26/MVA and MVA/Ad26 vaccines expressing
SIVSME543 were protected against SIVMAC251 challenge
(doi:10.1038/nature10766). Protection was associated
with Env-specific binding ELISA antibody responses,
including V2-specific antibodies.
Methods
We amplified 66 sequences from the SIV MAC251 chal-
lenge stock, and 409 near-full length genomes from 13
vaccine and 13 control monkeys. A series of pre-speci-
fied phylogenetic and statistical tests for sieve effects
was performed.
Results
The mean pairwise AA diversity among the 66 SIV-
MAC251 Env sequences was 0.38%, and they differed from
the vaccine strain SIV SME543 (Env) by 21.94%. The
repeated low-dose challenge resulted in infections with
an average of 1.7 founder variants - with no evidence
that the vaccine restricted the number of variants (p =
0.813). We explored whether the vaccine induced a
sieve effect, i.e. whether breakthrough viruses differed
between the vaccine and control groups. There was no
difference for full-length Env sequences. Focusing on
Env segments preferentially recognized by vaccinated
monkeys in antibody arrays, we identified a sieve effect
in the Env-V2 segment AA163-193: sequences from vac-
cinated animals were more divergent from the vaccine
SIVSME543 or from the challenge stock SIVMAC251 than
sequences in control animals (p ≤ 0.002).
Conclusion
The sieve effect in Env-V2, combined with Env-V2-spe-
cific binding antibodies identified as a correlate of pro-
tection against SIV MAC251 acquisition in the study,
provide evidence supporting the importance of protec-
tive responses directed against the Env-V2 region.
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